ATE412424T1 - Behandlung von druckgeschwüren - Google Patents

Behandlung von druckgeschwüren

Info

Publication number
ATE412424T1
ATE412424T1 AT05731043T AT05731043T ATE412424T1 AT E412424 T1 ATE412424 T1 AT E412424T1 AT 05731043 T AT05731043 T AT 05731043T AT 05731043 T AT05731043 T AT 05731043T AT E412424 T1 ATE412424 T1 AT E412424T1
Authority
AT
Austria
Prior art keywords
treatment
pressure ulcers
pressure
pressure sore
sore
Prior art date
Application number
AT05731043T
Other languages
English (en)
Inventor
Eric First
Original Assignee
Allergan Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Allergan Inc filed Critical Allergan Inc
Application granted granted Critical
Publication of ATE412424T1 publication Critical patent/ATE412424T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
    • A61K38/4886—Metalloendopeptidases (3.4.24), e.g. collagenase
    • A61K38/4893—Botulinum neurotoxin (3.4.24.69)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Dermatology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Food Preservation Except Freezing, Refrigeration, And Drying (AREA)
  • Processing Of Meat And Fish (AREA)
AT05731043T 2004-03-31 2005-03-28 Behandlung von druckgeschwüren ATE412424T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US10/814,764 US20050220821A1 (en) 2004-03-31 2004-03-31 Pressure sore treatment

Publications (1)

Publication Number Publication Date
ATE412424T1 true ATE412424T1 (de) 2008-11-15

Family

ID=34964467

Family Applications (1)

Application Number Title Priority Date Filing Date
AT05731043T ATE412424T1 (de) 2004-03-31 2005-03-28 Behandlung von druckgeschwüren

Country Status (10)

Country Link
US (2) US20050220821A1 (de)
EP (1) EP1729796B1 (de)
JP (2) JP2007531747A (de)
AT (1) ATE412424T1 (de)
AU (1) AU2005231360B2 (de)
BR (1) BRPI0509478A (de)
CA (1) CA2561588C (de)
DE (1) DE602005010676D1 (de)
DK (1) DK1729796T3 (de)
WO (1) WO2005097178A1 (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20060073208A1 (en) 2004-10-01 2006-04-06 Allergan, Inc. Cosmetic neurotoxin compositions and methods
FR2879462B1 (fr) * 2004-12-21 2008-12-26 Sod Conseils Rech Applic Utilisation de toxine botulique pour une insensibilisation locale prolongee
US20070238630A1 (en) * 2006-03-29 2007-10-11 Phillips Douglas H Subcutaneous skin cleanser
US20130251770A1 (en) * 2012-03-22 2013-09-26 Revance Therapeutics, Inc. Method of Treatment of Wrinkles Using Topical Chemodenervating Agents

Family Cites Families (50)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4330527A (en) * 1979-11-13 1982-05-18 Teruo Arima Wound treatment agent
US4805605A (en) * 1988-01-11 1989-02-21 Glassman Medical Products, Inc. Abduction pillow
US5393792A (en) * 1991-11-20 1995-02-28 Advance Biofactures Of Curacao, N.V. High dosage topical forms of collagenase
US5562907A (en) * 1993-05-14 1996-10-08 Arnon; Stephen S. Method to prevent side-effects and insensitivity to the therapeutic uses of toxins
US5437291A (en) * 1993-08-26 1995-08-01 Univ Johns Hopkins Method for treating gastrointestinal muscle disorders and other smooth muscle dysfunction
US7214787B1 (en) * 1993-09-21 2007-05-08 United States Of America As Represented By The Secretary Of The Army Recombinant vaccine against botulinum neurotoxin
JPH07118165A (ja) * 1993-10-22 1995-05-09 Asahi Chem Ind Co Ltd カルシトニン遺伝子関連ペプチド類を含有する経皮吸収組成物
US6974578B1 (en) * 1993-12-28 2005-12-13 Allergan, Inc. Method for treating secretions and glands using botulinum toxin
US5766605A (en) * 1994-04-15 1998-06-16 Mount Sinai School Of Medicine Of The City University Of New York Treatment of autonomic nerve dysfunction with botulinum toxin
EP0758900B1 (de) * 1994-05-09 2002-04-10 BINDER, William J. Botulinumtoxin ZUR REDUKTION VON Migraine -KOPFSCHMERZEN
US5670484A (en) * 1994-05-09 1997-09-23 Binder; William J. Method for treatment of skin lesions associated with cutaneous cell-proliferative disorders
JPH0840926A (ja) * 1994-08-03 1996-02-13 Yakurigaku Chuo Kenkyusho:Kk 皮膚潰瘍治療薬
GB9508204D0 (en) * 1995-04-21 1995-06-07 Speywood Lab Ltd A novel agent able to modify peripheral afferent function
EP0773788B1 (de) * 1995-06-06 2003-05-07 L. Bruce Pearce Verbesserte zusammensetzungen und verfahren zur chemodenervation mit neurotoxinen
US5851522A (en) * 1995-06-07 1998-12-22 Trustees Of Tufts College Enhancing keratinocyte migration
US6670337B1 (en) * 1998-01-29 2003-12-30 Yeda Reaearch And Development Co., Ltd. Facilitation of wound healing with CM101/GBS toxin
US6063768A (en) * 1997-09-04 2000-05-16 First; Eric R. Application of botulinum toxin to the management of neurogenic inflammatory disorders
BRPI9908182C1 (pt) * 1998-02-27 2021-05-25 Biora Ab composições de proteína de matriz para cura de feridas
US6524568B2 (en) * 1998-06-22 2003-02-25 Cytomedix, Inc. Enriched platelet wound healant
WO2000024419A1 (en) * 1998-10-27 2000-05-04 Mayo Foundation For Medical Education And Research Methods for enhancing wound healing
US6139845A (en) * 1999-12-07 2000-10-31 Allergan Sales, Inc. Method for treating cancer with a neurotoxin
US6429189B1 (en) * 1999-12-10 2002-08-06 Botulinum Toxin Research Associates, Inc. Cytotoxin (non-neurotoxin) for the treatment of human headache disorders and inflammatory diseases
US6143306A (en) * 2000-01-11 2000-11-07 Allergan Sales, Inc. Methods for treating pancreatic disorders
US6464986B1 (en) * 2000-04-14 2002-10-15 Allegan Sales, Inc. Method for treating pain by peripheral administration of a neurotoxin
US6299893B1 (en) * 2000-04-17 2001-10-09 Marvin Schwartz Method to reduce hair loss and stimulate hair regrowth
US6306423B1 (en) * 2000-06-02 2001-10-23 Allergan Sales, Inc. Neurotoxin implant
WO2002012479A2 (en) * 2000-08-07 2002-02-14 Zymogenetics, Inc. Zcys9: a member of the cystatin superfamily
JP4096115B2 (ja) * 2000-08-10 2008-06-04 輝夫 西田 皮膚創傷治癒促進剤
US6678651B2 (en) * 2000-09-15 2004-01-13 Mindspeed Technologies, Inc. Short-term enhancement in CELP speech coding
US6423319B1 (en) * 2000-10-04 2002-07-23 Allergan Sales, Inc. Methods for treating muscle injuries
AU2002228841C1 (en) * 2000-12-07 2006-11-23 Sangamo Biosciences, Inc Regulation of angiogenesis with zinc finger proteins
US7067317B2 (en) * 2000-12-07 2006-06-27 Sangamo Biosciences, Inc. Regulation of angiogenesis with zinc finger proteins
US20020192239A1 (en) * 2001-01-09 2002-12-19 Borodic Gary E. Use of botulinum toxin for the treatment of chronic facial pain
US7108683B2 (en) * 2001-04-30 2006-09-19 Kci Licensing, Inc Wound therapy and tissue management system and method with fluid differentiation
DK1411978T3 (da) 2001-07-27 2009-01-05 Univ Louisiana State Botulinum-toksin ved behandlingen eller forebyggelsen af acne
WO2003015808A1 (en) * 2001-08-16 2003-02-27 Hnat Thomas M Method and composition for treatment of wounds and burns
EP1487481A4 (de) * 2002-03-01 2005-11-23 Elan Pharm Inc Verfahren zur behandlung von nerveneinklemmungssyndromen
US20040009180A1 (en) * 2002-07-11 2004-01-15 Allergan, Inc. Transdermal botulinum toxin compositions
EA008744B1 (ru) * 2002-08-12 2007-08-31 Актавис Груп Хф. Применение соединений антагонистов кальцитонин генсвязанного пептида (cgrp) для лечения псориаза
US20040167223A1 (en) * 2002-09-03 2004-08-26 Popp Karl F. Topical antibacterial formulations
MX282672B (es) * 2002-10-10 2011-01-10 Diversa Corp Proteasas, acidos nucleicos que los codifican, y metodos de hacer y usar los mismos.
US8048423B2 (en) * 2003-12-09 2011-11-01 Allergan, Inc. Botulinum toxin therapy for skin disorders
CA2557814A1 (en) * 2004-03-01 2005-09-15 Lumen Therapeutics, Llc Compositions and methods for treating diseases
BRPI0508410B8 (pt) * 2004-03-03 2021-05-25 Revance Therapeutics Inc composições e métodos para a aplicação tópica e liberação transdérmica de toxinas botulínicas
JP2007536269A (ja) * 2004-05-07 2007-12-13 ファイトトックス リミテッド ゴニオトキシンを用いた創傷の治療方法
US7179474B2 (en) * 2004-09-03 2007-02-20 Allergan, Inc. Methods for treating a buttock deformity
US20060058238A1 (en) * 2004-09-15 2006-03-16 Lee Laurent-Applegate Fetal skin cell protein compositions for the treatment of skin conditions, disorders or diseases and methods of making and using the same
AU2005288758A1 (en) * 2004-09-27 2006-04-06 Merz Pharma Gmbh & Co. Kgaa Clostridial neurotoxins for use in tissue healing
AU2007213706B2 (en) * 2006-02-09 2010-11-25 Aderans Research Institute, Inc. Apparatus and methods for delivering fluid and material to a subject
US9283217B2 (en) * 2011-11-10 2016-03-15 Allergan, Inc. Pharmaceutical compositions comprising 7-(1 H-imidazol-4-ylmethyl)-5,6,7,8-tetrahydro-quinoline for treating skin diseases and conditions

Also Published As

Publication number Publication date
DE602005010676D1 (de) 2008-12-11
AU2005231360A1 (en) 2005-10-20
US8865177B2 (en) 2014-10-21
JP2007531747A (ja) 2007-11-08
WO2005097178A1 (en) 2005-10-20
CA2561588C (en) 2012-08-28
US20050220821A1 (en) 2005-10-06
DK1729796T3 (da) 2009-01-19
EP1729796A1 (de) 2006-12-13
EP1729796B1 (de) 2008-10-29
CA2561588A1 (en) 2005-10-20
JP2013075902A (ja) 2013-04-25
JP5674164B2 (ja) 2015-02-25
BRPI0509478A (pt) 2007-09-11
AU2005231360B2 (en) 2009-10-29
US20080050404A1 (en) 2008-02-28

Similar Documents

Publication Publication Date Title
DK2154151T3 (da) Clostridiumtoksinaktiverbare clostridiumtoksiner
TW200503751A (en) Methods for treating sinus headache
WO2019067815A3 (en) A neurotoxin-like toxin and uses thereof
DE60310400D1 (de) Botulinustoxine zur behandlung von priapismus
MXPA02009932A (es) Metodo apra el tratamiento del dolor mediante administracion periferica de una neurotoxina.
DE60142839D1 (de) Botulinum Toxin zur Behandlung von akuten Verletzungen der Skelettmuskeln
PT1492561E (pt) Metodo para tratar disturbios da glandula mamaria
ATE408416T1 (de) Intrakraniale behandlung neuropsychiatrischer krankheiten mit clostridium neurotoxinen wie botulinus toxin
DK0605501T5 (da) Anvendelse af præsynaptisk neurotoksin til behandling af cerebel parese
BRPI0910993A2 (pt) técnica de administração na linha de sutura usando toxinas botulínicas
ATE255418T1 (de) Neurotoxine zur behandlung von pankreatischen krankheiten
ATE392877T1 (de) Wundbehandlungsverband
DE60327528D1 (de) Transdermale botulinum-toxin-enthaltende verbindungen
NO20070391L (no) Jernsulfatbasert fosfatadsorbent
NO20050091L (no) Fremgangsmater for fremstilling av fibrinogen
MX2022010186A (es) Neurotoxinas botulinas para uso en terapia.
ATE462443T1 (de) Dehnungsstreifenbehandlung mit botulinumtoxin
DE60116642D1 (de) Verbindungen mit cytochrom p450ra1 hemmenden aktivität
ATE412424T1 (de) Behandlung von druckgeschwüren
BRPI0514836A (pt) uso de toxina botulìnica para tratamento de uma deformidade da nádega
DE60322395D1 (de) Antipruritisches mittel
DK1368023T3 (da) Anvendelse af buprenoprphin til behandling af urininkontinens
ATE360438T1 (de) Verwendung von inaktives cln2 proenzym zur behandlung von lincl
ATE529108T1 (de) Zellmigrationsmodulierende verbindungen
BR112021004776A2 (pt) Métodos para tratamento de hipertrofia do músculo masseter

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties